Jazz Pharmaceuticals Officer Neena Patil Files Form 144 for $289K Share Sale

Executive Summary

On September 10, 2026, Neena Patil, an Officer at Jazz Pharmaceuticals plc (CIK: 0001232524), submitted a Form 144 notice of proposed sale covering 1,200 common shares with an estimated aggregate market value of $289,128.00 (~$240.94 per share).

Transaction Details

• Security Type: Common Shares
• Number of Shares: 1,200
• Aggregate Market Value: $289,128.00
• Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
• Approximate Sale Date: September 10, 2026
• Shares Outstanding: 64,914,577
• Origination of Shares: Acquired as Restricted Stock directly from the issuer on March 5, 2026.

Trading Plan & Significance

• Rule 10b5-1 Trading Plan: The proposed sale is executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on February 26, 2026.
• Significance Level: Low
  • The transaction size of 1,200 shares is minimal relative to the company's 64.9M outstanding shares (<0.01%).
  • Execution under a pre-scheduled Rule 10b5-1 plan indicates standard executive diversification rather than a discretionary market signal.